Rentokil Initial (NYSE:RTO) Upgraded to Hold at Zacks Research

Zacks Research upgraded shares of Rentokil Initial (NYSE:RTO) from a strong sell rating to a hold rating in a research report sent to investors on Thursday morning,Zacks reports.

Several other analysts have also recently issued reports on RTO. Investec raised Rentokil Initial to a “buy” rating in a research note on Wednesday, September 23rd. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Rentokil Initial in a report on Monday, August 3rd. The Goldman Sachs Group reiterated a “buy” rating on shares of Rentokil Initial in a report on Monday, October 5th. Wall Street Zen cut Rentokil Initial from a “buy” rating to a “hold” rating in a research note on Monday, July 20th. Finally, BNP Paribas Exane downgraded Rentokil Initial from an “outperform” rating to a “neutral” rating and set a $26.70 target price for the company. in a report on Friday, July 31st. Seven investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Rentokil Initial presently has a consensus rating of “Hold” and a consensus target price of $31.90.

Rentokil Initial Price Performance

Rentokil Initial stock opened at $22.77 on Thursday. The business has a fifty day moving average price of $21.95 and a 200-day moving average price of $27.33. Rentokil Initial has a one year low of $19.50 and a one year high of $34.67. The company has a quick ratio of 0.98, a current ratio of 1.06 and a debt-to-equity ratio of 0.65.

Rentokil Initial Cuts Dividend

The company also recently disclosed a dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Friday, August 14th were given a dividend of $0.2240 per share. This represents a yield of 188.0%. The ex-dividend date of this dividend was Friday, August 14th. This is a negative change from Rentokil Initial’s previous dividend of $0.4120.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Iridian Asset Management LLC CT raised its holdings in Rentokil Initial by 54.2% in the third quarter. Iridian Asset Management LLC CT now owns 228,252 shares of the company’s stock worth $4,508,000 after purchasing an additional 80,182 shares in the last quarter. Vontobel Holding Ltd. bought a new stake in shares of Rentokil Initial during the 3rd quarter valued at $346,000. Diversified Management Inc. bought a new stake in shares of Rentokil Initial during the 3rd quarter valued at $289,000. Integrated Wealth Concepts LLC purchased a new stake in shares of Rentokil Initial in the 2nd quarter worth about $57,000. Finally, NewEdge Advisors LLC grew its position in shares of Rentokil Initial by 332.7% in the 2nd quarter. NewEdge Advisors LLC now owns 39,213 shares of the company’s stock worth $1,122,000 after buying an additional 30,151 shares during the period. Hedge funds and other institutional investors own 9.91% of the company’s stock.

Rentokil Initial News Roundup

Here are the key news stories impacting Rentokil Initial this week:

• Positive Sentiment: Share buyback supports the stock: Rentokil announced a $200 million share repurchase program, expected to begin shortly and be completed before full-year results. The buyback follows the $230 million sale of SOLitude Lake Management and should provide additional demand for the shares. Rentokil announces $200 million share buyback as third-quarter organic revenue grows 3.4%
• Positive Sentiment: Steady quarterly performance: Third-quarter revenue increased 4.0% to $1.89 billion, with organic revenue growth of 3.4%. Management maintained its expectation that 2026 profit will be in line with market forecasts, reducing near-term earnings risk. Rentokil announces $200 million buyback; quarterly revenue rises on improving North America business
• Positive Sentiment: North American outlook improves: UBS raised its price target to 390p from 370p and reiterated a “buy” rating, citing signs that performance in Rentokil’s key North American pest-control business is stabilizing. Rentokil’s price target raised by UBS as North America shows signs of stabilising
• Neutral Sentiment: Finance leadership transition: CFO Paul Edgecliffe-Johnson plans to retire on January 31. The departure adds a transition factor for investors, although no deterioration in current-year guidance was reported. Rentokil Initial CFO Paul Edgecliffe-Johnson To Retire From Jan 31
• Negative Sentiment: Persistent North American concerns: Broyhill Asset Management argued that weakness in North America undermines the investment case, highlighting the risk that stabilization may not yet translate into sufficiently strong growth or earnings momentum. Rentokil Initial plc North American weakness undermines the thesis
• Negative Sentiment: Longer-term strategic questions: Commentary has raised concerns about whether artificial intelligence could disrupt parts of Rentokil’s growth strategy, adding uncertainty beyond the company’s near-term results. AI Disruption Raises New Questions for Rentokil’s Growth Strategy

About Rentokil Initial

Rentokil Initial plc (NYSE:RTO) is a business services company headquartered in the United Kingdom. It provides pest control, hygiene, and workplace services to commercial, public-sector, and residential customers. Its offerings are designed to help organizations manage pests, maintain sanitary environments, and support health, safety, and workplace standards.

The company’s pest control services address insects, rodents, and other pests, while its hygiene operations provide washroom services, sanitary products, air care, floor-care solutions, and related workplace services.